Search

everythinglearnresearchcommunity

for

Search:↓

Regular follow-up visits, especially with dermatologists, can lower death rates for melanoma patients, with socioeconomic factors also affecting outcomes.

Melanoma survival rates vary by state and are better where incomes are higher, more people have health insurance and education, and there are more dermatologists.

SOX4 is crucial for the development of melanoma.

Tumor cell adhesion is linked to higher risk of SLN metastasis and melanoma recurrence, and a model including these factors predicts these outcomes better than one with just clinical data.

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

UV photography can help identify people at higher risk for skin cancer, and male pattern baldness at age 45 is linked to a higher risk of certain skin cancers.

Male pattern baldness is linked to a higher risk of certain skin cancers, especially on the scalp.

Certain microRNAs are linked to various skin diseases and could be used to diagnose and treat these conditions.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Dutasteride and minoxidil mesotherapy effectively treats hair loss with minimal side effects.

Melatonin receptors in hair follicles help regulate hair growth and could treat hair loss.

People with Down syndrome have a higher risk of skin disorders and need better screening and treatment.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

Fullerenes show potential in skin care but need more safety research.

Pregnancy can cause normal skin changes that usually go away after childbirth and don't need treatment.

Finasteride can cause one-sided breast enlargement, which disappears after stopping the drug.

Skin reactions from cancer treatments might predict how well the treatments work.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Most patients treated with low-dose alpha-interferon for malignant melanoma experienced skin side effects, with hair loss being the most frequent.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Stopping forehead irritation and using hydrocortisone helped a man's skin, Martinique has lower melanoma rates, a man had an allergy to a specific antifungal, another had unexplained cysts, certain drugs can cause skin reactions without always being interrelated, a link between Fanconi anemia and a skin condition was suggested, high levels of a certain protein may play a role in a type of psoriasis, and there's a need to study the connection between scalp pain and hair loss.

Correct skin biopsy techniques are crucial to avoid misdiagnosis of skin diseases.

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

The document concludes that various dermatological treatments and drugs can cause skin reactions and side effects.

Finding a positive nonsentinel lymph node in melanoma patients indicates a worse prognosis.

Melanoma survivors are more likely to use sunscreen and seek shade than others, but less than half often use sunscreen and avoid the sun, and some still use tanning beds.

The document concludes that the immune-inhibitory environment of the hair follicle may prevent melanoma development.

Putting thymidine dinucleotide on newborn mice's skin can delay and reduce skin cancer.